NCT04969887 Combination Immunotherapy in Rare Cancers Under InvesTigation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04965402 A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants Status COMPLETED Phase PHASE1
NCT04965389 A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants Status COMPLETED Phase PHASE1
NCT04963283 Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04956627 A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04949269 A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants Status COMPLETED Phase PHASE1
NCT04949113 Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04943900 A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors Status COMPLETED Phase PHASE1
NCT04941755 A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04938232 Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04936399 A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom Status COMPLETED Phase N/A
NCT04934696 A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential Status COMPLETED Phase PHASE1
NCT04933903 BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab Status RECRUITING Phase PHASE2
NCT04926051 A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption Status COMPLETED Phase PHASE1
NCT04925375 Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease Status RECRUITING Phase PHASE2
NCT04919122 Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase N/A